Companies/JP/4552

JCR PHARMACEUTICALS CO., LTD. · JCRファーマ株式会社

Income flow

Annual
4552 ANNUAL Income StatementPeriod 2026-03-31Source ANNUAL
Services & otherJPY 22BPharmaceutical BusinessJPY 18BMedical And Research Equipment BusinessJPY 478MRevenueJPY 40B+22% Y/YGross profitJPY 30B+36% Y/YCost of revenueJPY 10BOperating profitJPY 555MOperating expensesJPY 30BNet profitJPY 2BTaxJPY 1BSG&AJPY 30BR&D & otherJPY 1M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2017-03-31 · ANNUAL · JPY
By activity
By activityJPY 18.2B
  • Pharmaceutical BusinessJPY 17.7B97.4%
  • Medical And Research Equipment BusinessJPY 478M2.6%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).3.82%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.1.60%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).20PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.298.5%Shares outTotal shares currently outstanding (issued and not retired).122.0MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).73.7M
Upcoming dividend
Next ex-div
2027-03-30 · declared
Last cash
10 · 2027-03-30
Stock splits
  1. 4:12020-09-29